Status:
ACTIVE_NOT_RECRUITING
Mobile Integrated Health in Heart Failure
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to compare how two different types of care after a hospitalization reduce hospital readmissions and symptom burden. The two types of care are a Transitions of Care Coordin...
Detailed Description
High 30-day readmission rates among heart failure (HF) patients (25% nationally) inflict substantial burden on both health systems and patients. The majority of hospital readmissions occur in the firs...
Eligibility Criteria
Inclusion
- Medicare or Medicaid recipient
- Current diagnosis of HF
- Receiving inpatient care at NewYork Presbyterian or Mount Sinai Health Systems
- Live in NYC
Exclusion
- Non-English, Spanish, Mandarin, or French speaking
- Diagnosis of dementia or psychosis
- Anticipated discharge to, or current residence in, skilled nursing facility or rehab center
- Anticipated discharge to, or currently receiving, hospice including home hospice
- Current candidate for and awaiting heart transplant
- Current left ventricular assist device (LVAD)
Key Trial Info
Start Date :
January 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2025
Estimated Enrollment :
2005 Patients enrolled
Trial Details
Trial ID
NCT04662541
Start Date
January 4 2021
End Date
December 30 2025
Last Update
January 14 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Health System
New York, New York, United States, 10029
2
Columbia University Irving Medical Center
New York, New York, United States, 10032
3
New York Presbyterian/Weill Cornell Medicine
New York, New York, United States, 10065